VLON Vallon Pharmaceuticals, Inc.
Vallon Pharmaceuticals, Inc. engages in developing and manufacturing medicines for attention-deficit/hyperactivity disorder (ADHD) and narcolepsy disorder. The company was incorporated in 2018 and is based in Philadelphia, Pennsylvania.
$6.19
As of 02/26/2021 IEX book CBOE book
Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Health Care
Biotechnology
USA
02/10/2021
6,176,216
402,037
$37,736,680
0.00%
SEC Edgar Online
10-Q
10-K
Common stocks
Micro cap
Health Care
Biotechnology
USA
02/10/2021
6,176,216
402,037
$37,736,680
0.00%
SEC Edgar Online
10-Q
10-K
Valuation (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
-1,592.95
0.00
7,985.38%
0.00%
-1,592.95
0.00
7,985.38%
0.00%